1. Home
  2. MOLN vs ELMD Comparison

MOLN vs ELMD Comparison

Compare MOLN & ELMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MOLN
  • ELMD
  • Stock Information
  • Founded
  • MOLN 2004
  • ELMD 1992
  • Country
  • MOLN Switzerland
  • ELMD United States
  • Employees
  • MOLN N/A
  • ELMD N/A
  • Industry
  • MOLN
  • ELMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • MOLN
  • ELMD Health Care
  • Exchange
  • MOLN Nasdaq
  • ELMD Nasdaq
  • Market Cap
  • MOLN 183.2M
  • ELMD 190.6M
  • IPO Year
  • MOLN 2021
  • ELMD 2010
  • Fundamental
  • Price
  • MOLN $3.89
  • ELMD $20.54
  • Analyst Decision
  • MOLN
  • ELMD Strong Buy
  • Analyst Count
  • MOLN 0
  • ELMD 1
  • Target Price
  • MOLN N/A
  • ELMD $38.00
  • AVG Volume (30 Days)
  • MOLN 2.5K
  • ELMD 51.9K
  • Earning Date
  • MOLN 05-15-2025
  • ELMD 05-13-2025
  • Dividend Yield
  • MOLN N/A
  • ELMD N/A
  • EPS Growth
  • MOLN N/A
  • ELMD 60.99
  • EPS
  • MOLN N/A
  • ELMD 0.79
  • Revenue
  • MOLN $2,525,030.00
  • ELMD $61,439,000.00
  • Revenue This Year
  • MOLN N/A
  • ELMD $17.91
  • Revenue Next Year
  • MOLN $866.67
  • ELMD $11.70
  • P/E Ratio
  • MOLN N/A
  • ELMD $25.74
  • Revenue Growth
  • MOLN N/A
  • ELMD 14.85
  • 52 Week Low
  • MOLN $3.36
  • ELMD $13.74
  • 52 Week High
  • MOLN $12.70
  • ELMD $35.56
  • Technical
  • Relative Strength Index (RSI)
  • MOLN 49.48
  • ELMD 50.64
  • Support Level
  • MOLN $3.76
  • ELMD $20.00
  • Resistance Level
  • MOLN $4.13
  • ELMD $20.39
  • Average True Range (ATR)
  • MOLN 0.18
  • ELMD 0.57
  • MACD
  • MOLN 0.01
  • ELMD 0.15
  • Stochastic Oscillator
  • MOLN 50.00
  • ELMD 74.54

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

About ELMD Electromed Inc.

Electromed Inc is a United States-based company that develops, manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System and related products, to patients with compromised pulmonary function with a commitment to excellence and compassionate service. The SmartVest System features a programmable air pulse generator, a therapy garment worn over the upper body and a connecting hose, which together provide safe, comfortable, and effective airway clearance therapy.

Share on Social Networks: